Key points are not available for this paper at this time.
Chimeric antigen receptor (CAR) T cells targeting CD22 (CD22-CAR) provide a therapeutic option for patients with CD22
Building similarity graph...
Analyzing shared references across papers
Loading...
Liora M. Schultz
Nikeshan Jeyakumar
Anne Marijn Kramer
Leukemia
Stanford University
Building similarity graph...
Analyzing shared references across papers
Loading...
Schultz et al. (Fri,) studied this question.
www.synapsesocial.com/papers/68e73cb8b6db6435876b6061 — DOI: https://doi.org/10.1038/s41375-024-02220-y